Safety Study of GMDTC Injection in Healthy Participants

Clinical trial NCT05908383 · COMPLETED

Trial details

NCT number: NCT05908383
Sponsor: Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Cadmium Exposure

Start date: 2023-01-30
Primary completion: 2023-06-30
Enrollment: 76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.